SCHEMBL7681127

SCHEMBL7681127

CN(C)CCCNCc1[c]ccnc1N1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ PIK3CA P42336 8/20 0.37
▸ MTOR P42345 7/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ KCNH2 Q12809 1/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679170 0.85 CYP2C19 (0.53) KDM4EGAACYP2C19CYP3A4CYP2D6
SCHEMBL7679097 0.83 CYP2C19 (0.48) GAAPIK3CAMTORCYP2C19CYP3A4
SCHEMBL7675925 0.81 CYP2D6 (0.45) KDM4ECYP2C19CYP3A4CYP2D6ALDH1A1
SCHEMBL7679073 0.71 CYP3A4 (0.45) MKNK1KDM4EGAAPIK3CACYP2C19
SCHEMBL27457509 0.69 KDM4E (0.33) KDM4ECYP3A4ALDH1A1HPGDHSD17B10
SCHEMBL7672759 0.67 KDM4E (0.43) KDM4EPIK3CACYP2C19ALDH1A1HSD17B10
SCHEMBL7675337 0.66 PIK3R1 (0.40) KDM4EGAAPIK3CAMTORHSD17B10
SCHEMBL7673338 0.66 HRH3 (0.40) PIK3CALRRK2PIK3CGCYP2C9CYP1A2
SCHEMBL1602160 0.64 KDM4E (0.45) KDM4EGAAPIK3CAALDH1A1HPGD
SCHEMBL1599910 0.64 KDM4E (0.45) KDM4EGAAPIK3CAALDH1A1LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
Send feedback